ZYNEX INC: Bankruptcy Filing Overshadows SEC Investigation Closure

Here's the polished SEC filing summary for ZYNEX INC, focusing on clarity, engagement, flow, conciseness, active voice, and readability for retail investors, without altering facts or structure.

---

ZYNEX INC: Bankruptcy Filing Overshadows SEC Investigation Closure

ZYNEX INC, a medical device company, faces a critical financial restructuring. This summary details recent events crucial for investors: the company's Chapter 11 bankruptcy filing and the conclusion of an SEC investigation with no enforcement action.

What Happened: Key Events and Their Immediate Impact

Zynex Inc. recently experienced two significant developments:

• SEC Investigation Concludes with No Enforcement Action: On February 18, 2026, the U.S. Securities and Exchange Commission (SEC) confirmed it closed its investigation into Zynex Inc., deciding not to recommend any enforcement action. This outcome removes a potential legal and financial burden previously disclosed in the company's financial reports. However, this positive news is largely overshadowed by the company's severe financial distress.
• Chapter 11 Bankruptcy Filing: Zynex Inc. and certain subsidiaries filed for Chapter 11 bankruptcy protection on December 15, 2025. This action signals the company's inability to meet its financial obligations and manage its debt, requiring a court-supervised reorganization of its business and finances.

Immediate Consequences of Bankruptcy:

• Delisting and OTC Trading: The bankruptcy filing directly led to Zynex's common stock suspension from Nasdaq trading on December 24, 2025, and official delisting on February 2, 2026. The stock now trades on the less regulated OTC Pink Limited Market under the symbol "ZYXIQ," which typically means lower liquidity and higher price volatility.
• SEC Deregistration: The company's common stock is also scheduled for deregistration with the SEC, expected to become effective around April 2026 (approximately 90 days after January 23, 2026).

Who and What Is Affected: Impact Assessment

The bankruptcy filing profoundly impacts various stakeholders:

• Shareholders: Zynex explicitly warns shareholders of "significant loss" and the "likelihood of the cancellation of the Company’s common stock." This indicates a very high risk of losing most, if not all, of their investment.
• Creditors: Creditors will actively negotiate the restructuring plan, aiming to recover their outstanding debts.
• Employees: The filing notes "uncertainty regarding the Company’s ability to retain key personnel and management," suggesting potential instability and workforce changes.
• Customers: While the filing does not directly address customers, a company in bankruptcy often faces challenges maintaining product development, service levels, or supply chain stability.
• Company Operations: Zynex will continue to operate under Chapter 11 protection, subject to court supervision and creditor negotiations as it develops a "Restructuring Plan."

Financial Impact: Severe Distress

The Chapter 11 filing itself directly indicates severe financial distress and Zynex's inability to meet its obligations. The "High Risk for Shareholders" section clearly details the financial loss for equity holders, including the potential cancellation of common stock. Bankruptcy proceedings prioritize creditors, highlighting the significant financial implications for different capital providers.

Why This Matters for Investors

The Chapter 11 filing is a critical event signaling severe financial distress. While the SEC's decision offers minor relief, it does not change the fundamental challenges bankruptcy presents.

• High Risk for Shareholders: Zynex Inc. explicitly warns that trading its stock is "highly speculative." The company states that "equity holders will experience a significant loss on their investment if the restructuring transactions are implemented" and highlights the "likelihood of the cancellation of the Company’s common stock." This means current shareholders face a very high probability of losing most, if not all, of their investment, as creditors typically receive priority in bankruptcy, often gaining new equity that dilutes or eliminates existing shares.
• Impact on Operations and Stakeholders:
  • Creditors: They will actively negotiate the restructuring plan to recover their outstanding debts.
  • Employees: The filing mentions "uncertainty regarding the Company’s ability to retain key personnel and management," suggesting potential instability and workforce changes as the company streamlines operations.
  • Customers: A company in bankruptcy may face challenges maintaining product development, service levels, or supply chain stability.

What Happens Next: The Path Forward

Zynex will continue operating under Chapter 11 protection, working to develop and implement a "Restructuring Plan" to reorganize its debts and operations. This process involves:

• Court Supervision: The bankruptcy court must approve all significant corporate actions and the final reorganization plan.
• Creditor Negotiations: The company will negotiate with its creditors to agree on terms for debt repayment or conversion, which may include issuing new equity to creditors.
• Plan Confirmation: The ultimate goal is to emerge from bankruptcy with a confirmed reorganization plan, which will dictate the company's future structure and ownership.

Key Takeaways for Investors

• Extreme Speculation: Investing in Zynex Inc. stock (ZYXIQ) at this time is highly speculative and carries an extremely high risk of total loss. The company's own warnings about the likely cancellation or worthlessness of existing shares warrant serious consideration.
• Focus on Bankruptcy Proceedings: Investors should closely monitor bankruptcy court announcements regarding the restructuring plan, especially details concerning existing equity.
• SEC News is Secondary: Do not let the positive SEC investigation news distract from the overwhelming financial distress indicated by the Chapter 11 bankruptcy filing. Zynex remains in severe financial trouble, and existing shareholders face a near-certain loss of their investment.